SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Johnson & Johnson at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Johnson & Johnson brings 4 presentations to SITC 2026 in Phoenix. Its program centres on T-cell engagers and other bispecific antibodies, how they compare with cell therapy, and on launching biotech startups. A distinctive finding is that blocking IL-12/23 reduces the immune-related side effects of checkpoint drugs in preclinical models without losing their anti-tumor effect.

OrganizationSITC 2026 Attendance
Johnson & Johnson
New Brunswick, NJ
Large pharma
Pharmaceutical business of Johnson & Johnson, formerly Janssen, developing oncology medicines including bispecific antibodies and cell therapy.
Talk
Thu Nov 5
11:30am–11:50am
Workshop
Thu Nov 5
5:00pm–9:00pm
Launching Biotech Startups: Funding, Pitching, Partnerships
  1. 5:00pm–5:30pmWelcome Reception
  2. 5:40pm–6:40pmPharma Perspectives on External Innovation
  3. 6:45pm–7:20pmPanel: Pharma Perspectives on External Innovation
  4. 7:25pm–8:10pmPanel: Financing and Partnerships
  5. 8:10pm–9:00pmClosing Networking Reception

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Johnson & Johnson

Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction